{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:19:02Z","timestamp":1795029542720,"version":"4.10.2"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.meegid.2021.104707","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T20:10:59Z","timestamp":1610223059000},"page":"104707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Cefoperazone\/sulbactam: New composites against multiresistant gram negative bacteria?"],"prefix":"10.1016","volume":"88","author":[{"given":"Yee-Huang","family":"Ku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2021.104707_bb0005","first-page":"358","article-title":"Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates","volume":"22","author":"Afridi","year":"2012","journal-title":"J. Coll. Physicians Surg. Pak."},{"issue":"Suppl. 1","key":"10.1016\/j.meegid.2021.104707_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1469-0691.2007.01847.x","article-title":"Sulbactam-containing beta-lactamase inhibitor combinations","volume":"14","author":"Akova","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.meegid.2021.104707_bb0015","doi-asserted-by":"crossref","first-page":"ofy300","DOI":"10.1093\/ofid\/ofy300","article-title":"Epidemiology of bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae that are piperacillin-tazobactam-nonsusceptible but ceftriaxone-susceptible","volume":"5","author":"Baker","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104707_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/jcm.26.1.13-17.1988","article-title":"Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination","volume":"26","author":"Barry","year":"1988","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2021.104707_bb0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/dkm494","article-title":"Role of beta-lactamase inhibitors in enterobacterial isolates producing extended-spectrum beta-lactamases","volume":"61","author":"Bhattacharjee","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.5578\/mb.26289","article-title":"Evaluation of the efficacy of colistin\/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains","volume":"50","author":"\u00c7etinkol","year":"2016","journal-title":"Mikrobiyol. Bul."},{"key":"10.1016\/j.meegid.2021.104707_bb0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jmii.2017.08.026","article-title":"The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms","volume":"51","author":"Chang","year":"2018","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.meegid.2021.104707_bb0040","first-page":"2305","article-title":"Genetic characterization and in vitro activity of antimicrobial combinations of multidrug-resistant Acinetobacter baumannii from a general hospital in China","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.meegid.2021.104707_bb0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/1011-4564.196365","article-title":"Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan","volume":"36","author":"Chiang","year":"2016","journal-title":"J. Med. Sci."},{"key":"10.1016\/j.meegid.2021.104707_bb0050","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijantimicag.2009.12.009","article-title":"Mechanisms of resistance to ciprofloxacin, ampicillin\/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan","volume":"35","author":"Chiu","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2021.104707_bb0055","first-page":"62","article-title":"Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and\/or DHA-1 beta-lactamases in a Czech hospital","volume":"309","author":"Chud\u00e1ckov\u00e1","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.meegid.2021.104707_bb0060","series-title":"Performance Standards for Antimicrobial Susceptibility Testing. 26th (M100-S26)","author":"Clinical and Laboratory Standard Institute","year":"2016"},{"key":"10.1016\/j.meegid.2021.104707_bb0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jac\/42.6.793","article-title":"Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii","volume":"42","author":"Corbella","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0070","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.2147\/IDR.S206691","article-title":"Characterization of phenotypic and genotypic traits of carbapenem-resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia","volume":"12","author":"El-Badawy","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.meegid.2021.104707_bb0075","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00228-016-2045-x","article-title":"Pharmacokinetics of cefoperazone\/sulbactam in critically ill patients receiving continuous venovenous hemofiltration","volume":"72","author":"Gao","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.meegid.2021.104707_bb0080","first-page":"798","article-title":"Epidemiology investigation of carbapenems-resistant Klebsiella pneumoniae in burn care unit","volume":"35","author":"Gong","year":"2019","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"10.1016\/j.meegid.2021.104707_bb0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/1120009X.2020.1730087","article-title":"The effect of cefoperazone-sulbactam and piperacillin-tazobactam on mortality in gram-negative nosocomial infections","volume":"32","author":"Guclu","year":"2020","journal-title":"J. Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0090","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1128\/AAC.29.5.955","article-title":"Comparative evaluation of a new beta- lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases","volume":"29","author":"Gutmann","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0095","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1128\/AAC.33.6.951","article-title":"SHV-5, a novel SHV-type \u03b2-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams","volume":"33","author":"Gutmann","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0100","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.7754\/Clin.Lab.2017.170120","article-title":"The first Enterobacter cloacae co-producing NDM and OXA-48 carbapenemases and interhospital spread of OXA-48 and NDM-producing Klebsiella pneumoniae in Turkey","volume":"63","author":"Haciseyitoglu","year":"2017","journal-title":"Clin. Lab."},{"key":"10.1016\/j.meegid.2021.104707_bb0105","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ijantimicag.2018.03.020","article-title":"Role of association of OmpK35 and OmpK36 alteration and bla(ESBL) and\/or bla(AmpC) genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae","volume":"52","author":"Hamzaoui","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2021.104707_bb0110","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/AAC.48.5.1586-1592.2004","article-title":"In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains","volume":"48","author":"Higgins","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijantimicag.2014.06.015","article-title":"Global transcriptional response of Acinetobacter baumannii to a subinhibitory concentration of tigecycline","volume":"44","author":"Hua","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2021.104707_bb0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijantimicag.2006.02.017","article-title":"In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from intensive care units in Taiwan: SMART 2004 programme data","volume":"29","author":"Hung","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2021.104707_bb0125","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3343\/alm.2015.35.6.595","article-title":"Distribution of \u03b2-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey","volume":"35","author":"Iraz","year":"2015","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.meegid.2021.104707_bb0130","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/AAC.34.5.858","article-title":"Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases","volume":"34","author":"Jacoby","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jmii.2015.08.024","article-title":"Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative gram-negative bacilli to cefoperazone-sulbactam","volume":"50","author":"Jean","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.meegid.2021.104707_bb0140","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0732-8893(85)80005-5","article-title":"In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies","volume":"3","author":"Jones","year":"1985","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104707_bb0145","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1128\/jcm.25.9.1725-1729.1987","article-title":"In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination","volume":"25","author":"Jones","year":"1987","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2021.104707_bb0150","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1128\/AAC.00762-13","article-title":"Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam","volume":"57","author":"Kaitany","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1556\/030.66.2019.036","article-title":"Characterization of carbapenem-resistant but cephalosporin-susceptible Pseudomonas aeruginosa","volume":"66","author":"Khalili","year":"2019","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"10.1016\/j.meegid.2021.104707_bb0160","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF02185845","article-title":"In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria","volume":"8","author":"Kitzis","year":"1989","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104707_bb0165","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1093\/jac\/dkt275","article-title":"TEM-1 \u03b2-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii","volume":"68","author":"Krizova","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0170","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/AAC.33.11.1964","article-title":"Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam","volume":"33","author":"Kuck","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0175","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2147\/IDR.S175257","article-title":"Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms","volume":"11","author":"Lai","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.meegid.2021.104707_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/IDR.S181201","article-title":"In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"12","author":"Lai","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.meegid.2021.104707_bb0185","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019321","article-title":"Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: a systemic review and meta-analysis","volume":"99","author":"Lan","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.meegid.2021.104707_bb0190","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000107725","article-title":"Comparison of the pharmacokinetics of piperacillin and sulbactam during intermittent and continuous intravenous infusion","volume":"53","author":"Langgartner","year":"2007","journal-title":"Chemotherapy"},{"key":"10.1016\/j.meegid.2021.104707_bb0195","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0732-8893(99)00120-0","article-title":"In vitro evaluation of cefepime and other broad-spectrum beta-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samples. The Japan antimicrobial resistance study group","volume":"35","author":"Lewis","year":"1999","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104707_bb0200","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2147\/IDR.S174876","article-title":"Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia","volume":"11","author":"Li","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.meegid.2021.104707_bb0205","first-page":"161","article-title":"Treatment efficacy of tigecycline in comparison to cefoperazone\/sulbactam alone or in combination therapy for carbapenenm-resistant Acinetobacter baumannii infections","volume":"33","author":"Li","year":"2020","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.meegid.2021.104707_bb0210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1179\/1973947814Y.0000000203","article-title":"In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii","volume":"27","author":"Liu","year":"2015","journal-title":"J. Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00023-19","article-title":"Randomized noninferiority trial of cefoperazone-sulbactam versus cefepime in the treatment of hospital-acquired and healthcare-associated pneumonia","volume":"63","author":"Liu","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Pt 8","key":"10.1016\/j.meegid.2021.104707_bb0220","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1099\/jmm.0.044156-0","article-title":"Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins","volume":"61","author":"Lopes","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.meegid.2021.104707_bb0225","doi-asserted-by":"crossref","first-page":"332","DOI":"10.29271\/jcpsp.2020.03.332","article-title":"Effectiveness of cefoperazone-sulbactam alone and combined with tigecycline in the treatment of multi-drug resistant Acinetobacter Baumannii pulmonary infection","volume":"30","author":"Lv","year":"2020","journal-title":"J. Coll. Physicians Surg. Pak."},{"issue":"Pt 1","key":"10.1016\/j.meegid.2021.104707_bb0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1099\/jmm.0.050492-0","article-title":"Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009","volume":"62","author":"Ma","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.meegid.2021.104707_bb0235","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1128\/AAC.43.7.1669","article-title":"Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae","volume":"43","author":"Mart\u00ednez-Mart\u00ednez","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0240","first-page":"425","article-title":"Comparative in vitro activity of beta-lactam\/beta-lactamase inhibitor combinations against gram negative bacteria","volume":"122","author":"Mohanty","year":"2005","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.meegid.2021.104707_bb0245","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhin.2011.01.014","article-title":"Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalized patients","volume":"78","author":"Orsi","year":"2011","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.meegid.2021.104707_bb0250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.diagmicrobio.2010.12.012","article-title":"Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli","volume":"71","author":"Park","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104707_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085854","article-title":"Rapid molecular characterization of Acinetobacter baumannii clones with rep-PCR and evaluation of carbapenemase genes by new multiplex PCR in hospital district of Helsinki and Uusimaa","volume":"9","author":"Pasanen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.104707_bb0260","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.38.4.767","article-title":"Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases","volume":"38","author":"Payne","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0265","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.04808-14","article-title":"Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii","volume":"59","author":"Penwell","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0270","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3855\/jidc.11798","article-title":"Surveillance of carbapenem-resistant Klebsiella pneumoniae in Chinese hospitals - a five-year retrospective study","volume":"13","author":"Qu","year":"2019","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.meegid.2021.104707_bb0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12941-017-0248-3","article-title":"Molecular characterization of \u03b2-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii","volume":"16","author":"Raible","year":"2017","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.meegid.2021.104707_bb0280","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jac\/27.5.569","article-title":"Factors determining resistance to \u03b2-lactam combined with \u03b2-lactamase inhibitors in Escherichia coli","volume":"27","author":"Reguera","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0285","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/AAC.32.1.42","article-title":"Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination","volume":"32","author":"Reitberg","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.meegid.2021.104707_bb0290","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/29.6.701","article-title":"Effect of impaired renal function on the pharmacokinetics of coadministered cefoperazone and sulbactam","volume":"29","author":"Rho","year":"1992","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0295","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3855\/jidc.33","article-title":"Extended spectrum AmpC and metallo-\u03b2-lactamases in Serratia and Citrobacter spp. in a disc approximation assay","volume":"3","author":"Rizvi","year":"2009","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.meegid.2021.104707_bb0300","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijid.2019.11.006","article-title":"Antimicrobial activity of cefoperazone-sulbactam tested against gram-negative organisms from Europe, Asia-Pacific, and Latin America","volume":"91","author":"Sader","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104707_bb0305","doi-asserted-by":"crossref","first-page":"670","DOI":"10.12669\/pjms.333.12416","article-title":"Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas aeruginosa isolated from patients of respiratory tract infections in a Tertiary Care Hospital, Peshawar","volume":"33","author":"Samad","year":"2017","journal-title":"Pak. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.meegid.2021.104707_bb0310","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/AAC.32.5.730","article-title":"Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients","volume":"32","author":"Schwartz","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0315","doi-asserted-by":"crossref","first-page":"e01612","DOI":"10.1128\/AAC.01612-17","article-title":"Kinetics of sulbactam hydrolysis by \u03b2-lactamases, and kinetics of \u03b2-lactamase inhibition by sulbactam","volume":"61","author":"Shapiro","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0320","first-page":"224","article-title":"Comparative evaluation of the in-vitro activity of six \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against gram negative bacilli","volume":"7","author":"Sood","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.meegid.2021.104707_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079640","article-title":"Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.104707_bb0330","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/AAC.34.6.958","article-title":"Penetration of ampicillin and sulbactam in the lower airways during respiratory infections","volume":"34","author":"Valcke","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0335","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/jac\/dkw105","article-title":"LN-1-255, a penicillanic acid sulfone able to inhibit the class D carbapenemase OXA-48","volume":"71","author":"Vallejo","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0340","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/AAC.00797-10","article-title":"Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction","volume":"55","author":"Waltner-Toews","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0345","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12871-015-0012-1","article-title":"Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone\/sulbactam after craniotomy","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.meegid.2021.104707_bb0350","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/14740338.2020.1713090","article-title":"Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study","volume":"19","author":"Wang","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.meegid.2021.104707_bb0355","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01739027","article-title":"Concentrations of ampicillin and sulbactam in serum and in various compartments of the respiratory tract of patients","volume":"22","author":"Wildfeuer","year":"1994","journal-title":"Infection"},{"key":"10.1016\/j.meegid.2021.104707_bb0360","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/clinids\/24.3.494","article-title":"Beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam\/cefoperazone","volume":"24","author":"Williams","year":"1997","journal-title":"Clin. Infect. Dis."},{"issue":"Pt 9","key":"10.1016\/j.meegid.2021.104707_bb0365","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1099\/jmm.0.045799-0","article-title":"Porin alterations present in non-carbapenemase-producing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile","volume":"61","author":"Wozniak","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.meegid.2021.104707_bb0370","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijid.2014.01.017","article-title":"A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone\/sulbactam","volume":"23","author":"Xia","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104707_bb0375","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0732-8893(99)00019-X","article-title":"Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan antimicrobial resistance study group","volume":"34","author":"Yamaguchi","year":"1999","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104707_bb0380","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01947-17","article-title":"Molecular epidemiology and mechanism of sulbactam resistance in Acinetobacter baumannii isolates with diverse genetic backgrounds in China","volume":"62","author":"Yang","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0385","article-title":"OXA-23 is a prevalent mechanism contributing to sulbactam resistance in diverse Acinetobacter baumannii clinical strains","volume":"63","author":"Yang","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104707_bb0390","first-page":"893","article-title":"AmpC \u03b2-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients","volume":"68","author":"Younas","year":"2018","journal-title":"J. Pak. Med. Assoc."},{"key":"10.1016\/j.meegid.2021.104707_bb0395","first-page":"1244","article-title":"The status of drug resistance and ampC gene expression in Enterobacter cloacae","volume":"116","author":"Zhou","year":"2003","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.meegid.2021.104707_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22976","article-title":"Mutation of CarO participates in drug resistance in imipenem-resistant Acinetobacter baumannii","volume":"33","author":"Zhu","year":"2019","journal-title":"J. Clin. Lab. Anal."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:44:39Z","timestamp":1761576279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134821000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":80,"alternative-id":["S1567134821000046"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104707","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefoperazone\/sulbactam: New composites against multiresistant gram negative bacteria?","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104707"}}